Maternal Epidermal Growth Factor Promotes Neonatal Claudin-2 Dependent Increases in Small Intestinal Calcium Permeability. 2023

Megan R Beggs, and Kennedi Young, and Allen Plain, and Debbie D O'Neill, and Ahsan Raza, and Veit Flockerzi, and Henrik Dimke, and R Todd Alexander
Department of Physiology, University of Alberta, Edmonton, AB T6G 2H7, Canada.

A higher concentration of calcium in breast milk than blood favors paracellular calcium absorption enabling growth during postnatal development. We aimed to determine whether suckling animals have greater intestinal calcium permeability to maximize absorption and to identify the underlying molecular mechanism. We examined intestinal claudin expression at different ages in mice and in human intestinal epithelial (Caco-2) cells in response to hormones or human milk. We also measured intestinal calcium permeability in wildtype, Cldn2 and Cldn12 KO mice and Caco-2 cells in response to hormones or human milk. Bone mineralization in mice was assessed by μCT. Calcium permeability across the jejunum and ileum of mice were 2-fold greater at 2 wk than 2 mo postnatal age. At 2 wk, Cldn2 and Cldn12 expression were greater, but only Cldn2 KO mice had decreased calcium permeability compared to wildtype. This translated to decreased bone volume, cross-sectional thickness, and tissue mineral density of femurs. Weaning from breast milk led to a 50% decrease in Cldn2 expression in the jejunum and ileum. Epidermal growth factor (EGF) in breast milk specifically increased only CLDN2 expression and calcium permeability in Caco-2 cells. These data support intestinal permeability to calcium, conferred by claudin-2, being greater in suckling mice and being driven by EGF in breast milk. Loss of the CLDN2 pathway leads to suboptimal bone mineralization at 2 wk of life. Overall, EGF-mediated control of intestinal claudin-2 expression contributes to maximal intestinal calcium absorption in suckling animals.

UI MeSH Term Description Entries
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D002136 Calcium, Dietary Calcium compounds in DIETARY SUPPLEMENTS or in food that supply the body with calcium. Dietary Calcium
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D062446 Claudin-2 A claudin subtype that is associated with the formation of cation-selective channels and increased epithelial permeability. It is localized to the TIGHT JUNCTIONS of the PROXIMAL KIDNEY TUBULE and INTESTINAL EPITHELIUM. Claudin 2
D018938 Caco-2 Cells Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation. Caco 2 Cells,Caco-2 Cell,Cell, Caco-2,Cells, Caco-2

Related Publications

Megan R Beggs, and Kennedi Young, and Allen Plain, and Debbie D O'Neill, and Ahsan Raza, and Veit Flockerzi, and Henrik Dimke, and R Todd Alexander
September 2011, Journal of cellular physiology,
Megan R Beggs, and Kennedi Young, and Allen Plain, and Debbie D O'Neill, and Ahsan Raza, and Veit Flockerzi, and Henrik Dimke, and R Todd Alexander
June 1984, Acta endocrinologica,
Megan R Beggs, and Kennedi Young, and Allen Plain, and Debbie D O'Neill, and Ahsan Raza, and Veit Flockerzi, and Henrik Dimke, and R Todd Alexander
June 2009, Molecular carcinogenesis,
Megan R Beggs, and Kennedi Young, and Allen Plain, and Debbie D O'Neill, and Ahsan Raza, and Veit Flockerzi, and Henrik Dimke, and R Todd Alexander
July 2011, Oncogene,
Megan R Beggs, and Kennedi Young, and Allen Plain, and Debbie D O'Neill, and Ahsan Raza, and Veit Flockerzi, and Henrik Dimke, and R Todd Alexander
April 2007, The Journal of pharmacology and experimental therapeutics,
Megan R Beggs, and Kennedi Young, and Allen Plain, and Debbie D O'Neill, and Ahsan Raza, and Veit Flockerzi, and Henrik Dimke, and R Todd Alexander
November 1985, Lancet (London, England),
Megan R Beggs, and Kennedi Young, and Allen Plain, and Debbie D O'Neill, and Ahsan Raza, and Veit Flockerzi, and Henrik Dimke, and R Todd Alexander
July 1989, Endocrinology,
Megan R Beggs, and Kennedi Young, and Allen Plain, and Debbie D O'Neill, and Ahsan Raza, and Veit Flockerzi, and Henrik Dimke, and R Todd Alexander
November 2017, Journal of immunology (Baltimore, Md. : 1950),
Megan R Beggs, and Kennedi Young, and Allen Plain, and Debbie D O'Neill, and Ahsan Raza, and Veit Flockerzi, and Henrik Dimke, and R Todd Alexander
July 2009, Biochemical and biophysical research communications,
Megan R Beggs, and Kennedi Young, and Allen Plain, and Debbie D O'Neill, and Ahsan Raza, and Veit Flockerzi, and Henrik Dimke, and R Todd Alexander
January 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Copied contents to your clipboard!